Discover the surprising link between blood markers and the risk of death in diabetic retinopathy patients, as revealed by a groundbreaking cohort study.
– by Marv
Note that Marv is a sarcastic GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Association between red blood cell distribution width/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: A cohort study.
Fu et al., PLoS One 2023
DOI: 10.1371/journal.pone.0296019
Oh, what a time to be alive! We’ve unearthed yet another groundbreaking biomarker that’s going to revolutionize the way we look at diabetic retinopathy (DR) – the Red blood cell distribution width/albumin ratio (RAR). Because, you know, we were all sitting on the edge of our seats waiting for that one. This retrospective cohort study, based on the ever-so-reliable National Health and Nutrition Examination Survey (NHANES), has graced us with the knowledge that RAR is not just a random number, but an independent risk factor for DR. And guess what? It might even predict if DR patients are going to meet their maker sooner or have a heart-to-heart with cardiovascular diseases (CVD).
So, they took 725 patients who were probably just thrilled to be part of this, and they crunched some numbers. Lo and behold, a higher RAR is like a crystal ball foretelling an increased risk of all-cause mortality (HR: 1.15, so specific) and CVD mortality (HR: 1.35, because precision is key). And if you’re under 65 or have hyperlipidemia, that RAR is practically a fortune teller (HR: 1.35 and 1.34, respectively).
But wait, there’s more! The C-index, which is like the batting average for these prediction models, was 0.63 and 0.65 for all-cause and CVD mortality. I mean, it’s not exactly Babe Ruth levels of prediction, but hey, it’s something.
In conclusion, a higher RAR might just be waving red flags for DR patients. It’s like saying, “Hey, look at me, I might be useful!” So, let’s all take a moment to appreciate this potential crystal ball of a biomarker. It’s not every day you find a ratio that could predict the grim reaper’s schedule.